Accrued expenses consisted of the following (in thousands):
As of March 31,
As of December 31,
2026
2025
Accrued pre-clinical and clinical trial costs
$
1,963
661
Accrued professional services and other
844
646
Total accrued expenses
2,807
1,307
No definition available.
Tabular disclosure of the components of accrued liabilities.